Bristol-Myers Squibb Co (NYSE:BMY)

58.23
Delayed Data
As of Apr 08
 -0.02 / -0.03%
Today’s Change
42.48
Today|||52-Week Range
68.34
-9.28%
Year-to-Date
2 Top U.S. Stocks to Watch in April
Apr 08 / MotleyFool.com - Paid Partner Content
Should You Buy Illumina Stock During the Coronavirus Bear Market?
Apr 05 / MotleyFool.com - Paid Partner Content
Got $3,000 to Invest? These 3 Stocks Could be Just What You're Looking For.
Apr 08 / MotleyFool.com - Paid Partner Content
Should I Trade My Growth Stocks for Value Stocks?
Apr 03 / MotleyFool.com - Paid Partner Content
Merck's Keytruda Receives Priority Review for a Key Indication
Apr 07 / MotleyFool.com - Paid Partner Content
Top 3 Healthcare Stocks to Buy Right Now
Apr 02 / MotleyFool.com - Paid Partner Content
Former Celgene Drug Earns a Key Approval for Bristol Myers Squibb
Apr 06 / MotleyFool.com - Paid Partner Content
Do Clinical Trial Delays Mean Trouble for Pharmaceutical Stocks?
Apr 01 / MotleyFool.com - Paid Partner Content
30 Top Stocks and Funds to Beat the COVID-19 Bear Market
Apr 05 / MotleyFool.com - Paid Partner Content
4 Reasons Drug Stocks Are a Buy Right Now
Mar 30 / MotleyFool.com - Paid Partner Content

Today’s Trading

Previous close58.25
Today’s open57.09
Day’s range56.37 - 58.80
Volume928
Average volume (3 months)16,301,869
Market cap$124.8B
Data as of 7:55pm ET, 04/08/2020

Growth & Valuation

Earnings growth (last year)-33.05%
Earnings growth (this year)+32.02%
Earnings growth (next 5 years)+9.76%
Revenue growth (last year)+15.89%
P/E ratio29.0
Price/Sales4.20
Price/Book2.38

Competitors

 Today’s
change
Today’s
% change
LLYEli Lilly and Co-0.19-0.13%
ABBVAbbVie-0.04-0.05%
AZNAstraZeneca-0.03-0.07%
SNYSanofi+0.58+1.30%
Data as of 4:00pm ET, 04/08/2020

Financials

Next reporting dateApril 23, 2020
EPS forecast (this quarter)$1.45
Annual revenue (last year)$26.1B
Annual profit (last year)$3.4B
Net profit margin13.15%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Major
No executives to display
Corporate headquarters
New York, New York

Forecasts